Taurolidine Irrigation Reduces Relapse and Recurrence of Hemodialysis Access Infection
1Department of Thoracic and Cardiovascular Surgery, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Background:
Infection of hemodialysis access is a clinically important concern and can lead to increased morbidity and mortality among patients on hemodialysis. In this study, we aimed to determine whether using taurolidine as an irrigating antiseptic after drainage of pus or removal of infected tissue and graft during surgery decreases the relapse and recurrence of infection.
Methods:
Between January 2016 and December 2023, 48 episodes in 38 patients hospitalized and treated for hemodialysis access infections were examined. Relapse, recurrence, and mortality of infection were analyzed in patients who received additional taurolidine irrigation versus those who did not. After drainage alone or after total or partial graft removal, all patients received massive irrigation with normal saline. The episodes of infection were examined consecutively during follow-up.
Results:
The majority (97.9%) of hemodialysis access infections was arteriovenous grafts (AVGs) or interposed grafts from native veins. In AVGs, infections occurred primarily after a median of 523 days from the first needling. All prosthetic materials that were the infection foci were removed in 58.3% of the cases, with partial resection and bypass or drainage performed in the remaining cases. The most common pathogen was Staphylococcus aureus (45.8%). After surgical intervention, relapse was observed in 12.5% of the cases and recurrence in 20.8% of the cases. The relapse occurrence was significantly reduced by taurolidine irrigation (odds ratio [OR]: 0.16, 95% confidence interval [CI]: 0.02-0.98, P = 0.05) and the total resection of prosthetic material (OR: 0.07, 95% CI: 0.01-0.70, P = 0.02). Recurrence was significantly decreased by taurolidine irrigation (OR: 0.10, 95% CI: 0.02-0.56, P = 0.01) and increased dramatically in cases with relapse history (OR: 8.50, 95% CI: 1.69-42.76, P < 0.01). Finally, male sex (hazard ratio: 7.01, 95% CI: 1.19-41.40, P = 0.03) and AVG (hazard ratio: 4.49, 95% CI: 1.01-20.01, P = 0.05) were significantly associated with increased overall mortality in infected hemodialysis access.
Conclusions:
Additional taurolidine irrigation after surgical resection significantly reduced the relapse and recurrence of infection in hemodialysis access. Taurolidine appears to be a safe and useful antiseptic for the control of hemodialysis access infection.
Insights
Taurolidine irrigation after surgery significantly reduces infection relapse and recurrence in hemodialysis access. This antiseptic is safe and effective for managing these serious infections.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Nephrology
Background:
- Hemodialysis access infections pose significant risks, increasing morbidity and mortality.
- Effective management strategies are crucial for patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of taurolidine irrigation in preventing infection relapse and recurrence after surgical treatment of hemodialysis access infections.
Main Methods:
- A retrospective study of 48 infection episodes in 38 patients from January 2016 to December 2023.
- Comparison of outcomes between patients receiving additional taurolidine irrigation and those who did not, following surgical intervention.
Main Results:
- Taurolidine irrigation significantly reduced infection relapse (OR: 0.16) and recurrence (OR: 0.10).
- Total resection of prosthetic material also decreased relapse.
- Male sex and arteriovenous grafts were associated with increased mortality.
Conclusions:
- Additional taurolidine irrigation is a safe and effective adjunct to surgical treatment for hemodialysis access infections.
- It significantly lowers the rates of infection relapse and recurrence.
More Related Videos
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
07:30Transcanalicular Diode Laser-assisted Dacryocystorhinostomy for the Treatment of Primary Acquired Nasolacrimal Duct Obstruction
Published on: October 13, 2017
Related Concept Videos
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemodialysis II: Procedure and Complications
Kidney Transplant III: Nursing Management
Hemodialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care
